Cargando…

Pharmacotherapy of pediatric and adolescent HIV infection

Significant advances have been made in the treatment of human immunodeficiency virus (HIV) infection over the past two decades. Improved therapy has prolonged survival and improved clinical outcome for HIV-infected children and adults. Sixteen antiretroviral (ART) medications have been approved for...

Descripción completa

Detalles Bibliográficos
Autor principal: Schuval, Susan J
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2701488/
https://www.ncbi.nlm.nih.gov/pubmed/19707256
_version_ 1782168703021875200
author Schuval, Susan J
author_facet Schuval, Susan J
author_sort Schuval, Susan J
collection PubMed
description Significant advances have been made in the treatment of human immunodeficiency virus (HIV) infection over the past two decades. Improved therapy has prolonged survival and improved clinical outcome for HIV-infected children and adults. Sixteen antiretroviral (ART) medications have been approved for use in pediatric HIV infection. The Department of Health and Human Services (DHHS) has issued “Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection”, which provide detailed information on currently recommended antiretroviral therapies (ART). However, consultation with an HIV specialist is recommended as the current therapy of pediatric HIV therapy is complex and rapidly evolving.
format Text
id pubmed-2701488
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-27014882009-08-25 Pharmacotherapy of pediatric and adolescent HIV infection Schuval, Susan J Ther Clin Risk Manag Review Significant advances have been made in the treatment of human immunodeficiency virus (HIV) infection over the past two decades. Improved therapy has prolonged survival and improved clinical outcome for HIV-infected children and adults. Sixteen antiretroviral (ART) medications have been approved for use in pediatric HIV infection. The Department of Health and Human Services (DHHS) has issued “Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection”, which provide detailed information on currently recommended antiretroviral therapies (ART). However, consultation with an HIV specialist is recommended as the current therapy of pediatric HIV therapy is complex and rapidly evolving. Dove Medical Press 2009 2009-06-22 /pmc/articles/PMC2701488/ /pubmed/19707256 Text en © 2009 Schuval, publisher and licensee Dove Medical Press Ltd. This is an Open Access article which permits unrestricted noncommercial use, provided the original work is properly cited.
spellingShingle Review
Schuval, Susan J
Pharmacotherapy of pediatric and adolescent HIV infection
title Pharmacotherapy of pediatric and adolescent HIV infection
title_full Pharmacotherapy of pediatric and adolescent HIV infection
title_fullStr Pharmacotherapy of pediatric and adolescent HIV infection
title_full_unstemmed Pharmacotherapy of pediatric and adolescent HIV infection
title_short Pharmacotherapy of pediatric and adolescent HIV infection
title_sort pharmacotherapy of pediatric and adolescent hiv infection
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2701488/
https://www.ncbi.nlm.nih.gov/pubmed/19707256
work_keys_str_mv AT schuvalsusanj pharmacotherapyofpediatricandadolescenthivinfection